SARASOTA, Fla., June 2, 2014
/PRNewswire/ -- Caribbean International Holdings (OTC:
CIHN) announced today that 70 million of the 75 million shares
issued by the Company as part of a venture in association with
South Of The Border Holdings, has been returned to the Company by
the shareholder. The venture was intended to own & operate
several "South Of The Border" restaurants in the Dominican Republic and other nearby
countries.
The Chairman and CEO of Caribbean International Holdings,
stated, "The key man in "South of the Border Holdings" has taken
ill and is unable to provide the services/duties on a day-to-day
basis that were key components of the deal, so we worked out a
return of company stock issued at the inception of the deal. The
Company has retired the stock to its treasury, which has in
turn reduced the outstanding shares of the common stock of
the Company.
Prior to the share cancellation, the Company's transfer agent,
Transfer Online, showed the Company's outstanding shares ("O/S") of
common stock to be 407,487,873. As of the close of business
May 29, 2014, after the cancellation
of the 70 million, the O/S, as reflected on the Transfer Online
website, was reduced to 337,487,873. That is approximately a 17%
reduction in the O/S.
The Company plans to dispose of all assets not related to its
stem cell activities. This will allow the Company to place it's
focus squarely on its subsidiary, Regenerative BioScience,
Inc.,".
The Company also announced that its "Ask The Doctor" feature has
been added to the Company website.
About The Company:
Caribbean International Holdings, Inc. is a holding company for
Regenerative Bio Science, Inc. ("RBSI"). The Company subsidiary
RBSI is focused on helping individuals protect and ensure their
future quality of life through Adult Stem Cell Incubation and the
practice of regenerative medicine in the
United States and the Dominican
Republic. RBSI's mission is not only to allow patients to
store their Stem Cells for future use, but also perform patient
funded stem cell therapies for degenerative diseases such as MS,
Arthritis, Degenerative Heart Diseases, Diabetes and a host of
experimental therapies in the brain trauma disease sector including
CTE. The goal is to become a global leader in establishing
protocols that can be patented and utilized to heal patients around
the world.
Adult stem cells work as the repairmen of the body by
replenishing and regenerating damaged tissues and cells. Certain
conditions have shown marked improvement when treated with adult
stem cells taken from the patient's own body. Regenerative
BioScience is a revolution in healthcare using a patient's own
adult stem cells.
For more information go to:
http://www.regenerativebioscience.com/index.html
Forward-Looking Statements
Except for statements of
historical fact, the matters discussed in this press release are
forward looking and made pursuant to the Safe Harbor provisions of
the Private Securities Litigation Reform Act of 1995.
"Forward-looking statements" describe future expectations, plans,
results, or strategies and are generally preceded by words such as
"future," "plan" or "planned," "expects," or "projected." These
forward-looking statements reflect numerous assumptions and involve
a variety of risks and uncertainties, many of which are beyond the
company's control that may cause actual results to differ
materially from stated expectations. These risk factors include,
among others, limited operating history, difficulty in developing,
exploiting and protecting proprietary technologies, intense
competition and additional risks factors as discussed in reports
filed by the company with the Securities and Exchange Commission,
which are available on at http://www.sec.gov.
Investor Contact:
BioScience
(941) 924-9400
SOURCE Caribbean International Holdings